The Chief Medical Officer issued a statement which reported that three patients who had suffered from vCJD had been blood donors, and a fourth was suspected of having been one too. Read more about The Chief Medical Officer issued a statement which reported that three patients who had suffered from vCJD had been blood donors, and a fourth was suspected of having been one too.
The MSBT discussed how to manage donors known to have received blood from people who subsequently developed vCJD. The outcome was reported to Dr Angela Robinson in her role as medical director of the National Blood Authority. Read more about The MSBT discussed how to manage donors known to have received blood from people who subsequently developed vCJD. The outcome was reported to Dr Angela Robinson in her role as medical director of the National Blood Authority.
From the end of 1999, no UK plasma was used. Read more about From the end of 1999, no UK plasma was used.
Alan Milburn, Secretary of State for Health, announced further details of the compensation scheme. Read more about Alan Milburn, Secretary of State for Health, announced further details of the compensation scheme.
People with a bleeding disorder were informed by their haemophilia centre and given an opportunity to discuss the implications and to find out if they had received an implicated batch if they wished. Read more about People with a bleeding disorder were informed by their haemophilia centre and given an opportunity to discuss the implications and to find out if they had received an implicated batch if they wished.
A second case of transfusion-related vCJD was reported in July 2004. Read more about A second case of transfusion-related vCJD was reported in July 2004.
The CJD Incidents Panel wrote to those responsible for tracing vCJD-implicated plasma batches setting out tables of implicated batch numbers. Read more about The CJD Incidents Panel wrote to those responsible for tracing vCJD-implicated plasma batches setting out tables of implicated batch numbers.
It was confirmed that a post-mortem carried out on a man with haemophilia found the vCJD prion in his spleen. He did not die of vCJD; nor was it present in the brain. The probability was that he had been infected and that the likeliest cause was his treatment with plasma product. Read more about It was confirmed that a post-mortem carried out on a man with haemophilia found the vCJD prion in his spleen. He did not die of vCJD; nor was it present in the brain. The probability was that he had been infected and that the likeliest cause was his treatment with plasma product.
A fourth case of vCJD transmission was associated with blood transfusion and was reported to the press. Read more about A fourth case of vCJD transmission was associated with blood transfusion and was reported to the press.
The chief medical officers of each of the four nations responded to a request to approve the framework for the management of possible exposures to CJD through medical procedures. Read more about The chief medical officers of each of the four nations responded to a request to approve the framework for the management of possible exposures to CJD through medical procedures.